Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

2012256 citationsJournal Articlebronze Open Access

Authors

The addition of bevacizumab to gemcitabine/cisplatin in this trial did not significantly improve PFS or OS in patients with advanced MM.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 30, Issue 20, pp. 2509-2515

Field-Weighted Citation Impact: 21.00